code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Inclusion Term:
Defective biosynthesis of testicular androgen NOS
5-delta-Reductase deficiency (with male pseudohermaphroditism)
Testicular hypogonadism NOS
↓
E29 Description: Testicular dysfunction Exclude1:
androgen insensitivity syndrome (E34.5-)
azoospermia or oligospermia NOS (N46.0-N46.1)
isolated gonadotropin deficiency (E23.0)
Klinefelter's syndrome (Q98.0-Q98.1, Q98.4)
↓
E20-E35 Description: Disorders of other endocrine glands (E20-E35) Exclude1:
galactorrhea (N64.3)
gynecomastia (N62)
↓
E00-E89 Description: Endocrine, nutritional and metabolic diseases Exclude1:
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.